Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
For the full year,net profit declined 7.65% to Rs 93.18 crore in the year ended March 2026 as against Rs 100.90 crore during the previous year ended March 2025. Sales declined 0.54% to Rs 354.33 crore in the year ended March 2026 as against Rs 356.27 crore during the previous year ended March 2025.
Abans Financial Services Ltd, Novartis India Ltd, Centum Electronics Ltd and BLB Ltd are among the other gainers in the BSE's 'B' group today, 20 February 2026.
VL E-Governance & IT Solutions Ltd surged 19.94% to Rs 17.32 at 20-Feb-2026 EOD IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 7.47 lakh shares were traded on the counter so far as against the average daily volumes of 1.43 lakh shares in the past one month.
Abans Financial Services Ltd soared 15.92% to Rs 233. The stock was the second biggest gainer in 'B' group. On the BSE, 0 shares were traded on the counter so far as against the average daily volumes of 14179 shares in the past one month.
Novartis India Ltd spiked 14.43% to Rs 950.25. The stock was the third biggest gainer in 'B' group. On the BSE, 8.22 lakh shares were traded on the counter so far as against the average daily volumes of 17776 shares in the past one month.
Centum Electronics Ltd jumped 14.22% to Rs 2623.45. The stock was the fourth biggest gainer in 'B' group. On the BSE, 35572 shares were traded on the counter so far as against the average daily volumes of 5040 shares in the past one month.
BLB Ltd added 13.33% to Rs 20.4. The stock was the fifth biggest gainer in 'B' group. On the BSE, 1.05 lakh shares were traded on the counter so far as against the average daily volumes of 26852 shares in the past one month.
The open offer price has been fixed at Rs 860.64 per share, representing a premium of 3.64% to the previous closing price of Rs 830.45. The acquirers propose to purchase up to 6,419,608 fully paid-up equity shares of face value Rs 5 each, aggregating to a total consideration of Rs 552.49 crore, payable in cash, assuming full acceptance.
The underlying promoter stake transaction is valued at approximately Rs 1,445.89 crore, subject to customary adjustments as per the agreement. Upon completion of the share purchase and assuming full subscription to the open offer, the acquirers’ combined shareholding will increase to 96.68%. In the event of nil tendering, their holding will remain at 70.68%.
Post completion, Novartis AG will hold nil stake in the company and cease to be the promoter, with its shareholding reclassified to the public category in accordance with SEBI regulations. The acquirers have stated that they do not intend to delist the company and will ensure compliance with the minimum public shareholding requirement, if necessary.
Separately, the company has agreed to change its name to remove all references to the seller group within 120 days from closing and will undertake requisite regulatory filings and other post-closing obligations. The deal marks a change in ownership from a global pharmaceutical major to a private equity-led consortium, while the company continues to remain listed.
Novartis India is primarily engaged in the wholesale distribution of pharmaceuticals and medical goods.
The company’s standalone net profit declined 36.8% to Rs 16.09 crore on a 7.6% drop in revenue from operations to Rs 85.90 crore in Q3 FY26 over Q3 FY25.